Clinical Trials Directory

Trials / Terminated

TerminatedNCT01820507

Extubation Failure Prevention in High Risk Patients by High-flow Conditioned Oxygen Therapy vs. Standard Oxygen Therapy

Prevention of Post-extubation Respiratory Failure in High Risk Patients by High-flow Conditioned Oxygen Therapy Versus Standard Oxygen Therapy

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
155 (actual)
Sponsor
Althaia Xarxa Assistencial Universitària de Manresa · Academic / Other
Sex
All
Age
18 Years – 95 Years
Healthy volunteers
Not accepted

Summary

Failure of extubation after mechanical ventilation is a frequent and deleterious issue. Main reasons for failure are hypoxemia, secretions retention, lung collapse and excessive work of breathing. Most of this issues can be partly counterbalanced by a device named "High flow conditioned oxygen therapy (HFCO)". Then, our hypothesis is that HFCO may reduce the incidence of respiratory failure after extubation in patients with high risk for failure.

Conditions

Interventions

TypeNameDescription
DEVICEOptiflow (Fisher&Paykel)The described method of oxygen supply will be maintained continuously for the first 24 hours after extubation.
DEVICENasal cannulae or controlled oxygen concentration maskThe described method of oxygen supply will be maintained continuously for the first 24 hours after extubation.

Timeline

Start date
2013-03-01
Primary completion
2014-11-01
Completion
2015-01-01
First posted
2013-03-28
Last updated
2015-01-30

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT01820507. Inclusion in this directory is not an endorsement.